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A CCURATE measurement of nociception during anes-thesia remains a challenging task. Nociception, which 
is defined as the neural process of encoding and processing 
noxious stimuli (noxious stimuli are actually or potentially 
tissue damaging events),1 will elicit behavioral, autonomic, 
and hormonal responses in conscious and unconscious indi-
viduals. Detection of behavioral responses during anesthesia 
is often impossible because of the use of muscle relaxants. 
Hence, we rely mostly on the autonomic responses to assess 
the nociception level (NoL) of the patient. Most anesthe-
sia healthcare providers, if not all, use changes in heart rate 
(HR) and blood pressure as markers of the occurrence of 
acute nociceptive events. Although these variables may suf-
fice when intense nociceptive stimuli occur, mild and mod-
erate stimuli are often not detected or detected too late.2
In recent years, various indices of nociception have been 
developed with varying success in actually detecting nocicep-
tive events. These indices derive a numerical value from single 
variables (such as heart rate variability [HRV], skin conduc-
tance, skin vasomotor reflex, the electroencephalogram, 
pupil diameter) or a combination of signals.3–11 In the cur-
rent study, we apply a new index of nociception, the NoL 
index.2 The NoL is a multiparameter nonlinear combination 
of HR, HRV, amplitude of the finger photoplethysmogram 
(AP), skin conductance level, fluctuations in skin conduc-
tance, and their time derivatives, derived from random 
forest regression. Random forest is an algorithmic model-
ing approach that enables combining multiple parameters 
of different origin and discovering their complex nonlinear 
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ABSTRACT
Background: A novel multidimensional index of nociception, the nociception level (NoL) index, derived from the nonlinear 
composite of heart rate (HR), HR variability, amplitude of the photoplethysmogram, skin conductance, fluctuations in skin 
conductance, and their time derivatives, was used to assess nociception during anesthesia.
Methods: Seventy-two American Society of Anesthesiologists I to III patients received propofol (target bispectral index, 45) 
and one of six remifentanil target concentrations in the range of 0 to 5 ng/ml. The NoL, mean arterial pressure (MAP; derived 
from a beat-to-beat finger cuff measurement), and HR were measured during nonnoxious, moderate noxious (skin incision), 
and intense noxious (intubation) stimulation. Values are represented as average (95% CI).
Results: NoL, HR, and MAP did not change during nonnoxious events. Incision increased HR by 1.3/min (−0.46 to 3.1/min; 
not significant), MAP by 7.9 mmHg (−1.9 to 13.0 mmHg; not significant), and NoL by 8.0 (0.4 to 16.0; P < 0.001).  Intubation 
increased HR by 7.0/min (1.4 to 12.0/min; P < 0.001), MAP by 13.0 mmHg (3.1 to 20 mmHg; P < 0.001), and NoL by 
18.0 (7.8 to 29.0; P < 0.001). The ΔNoL area under the curve (0.95) of the receiver operating characteristic curve was greater 
compared with ΔHR (0.84, P < 0.001) and ΔMAP (0.78, P < 0.001). Under nonnociceptive conditions, remifentanil had 
no effect on NoL, in contrast to HR and MAP that showed a dose-dependent decrease.
Conclusions: The NoL is a reliable measure of moderate and intense noxious stimulation and outperforms HR and MAP in 
differentiating noxious from nonnoxious stimuli. In contrast to HR and MAP, the NoL was not affected by hemodynamic 
effects of remifentanil. (Anesthesiology 2015; 123:00-00)
This article is featured in “This Month in Anesthesiology,” page 1A. Supplemental Digital Content is available for this article. Direct URL 
citations appear in the printed text and are available in both the HTML and PDF versions of this article. Links to the digital files are provided 
in the HTML text of this article on the Journal’s Web site (www.anesthesiology.org). Full protocol available at: a.dahan@lumc.nl. Raw data 
available at: a.dahan@lumc.nl.
Submitted for publication November 24, 2014. Accepted for publication May 16, 2015. From the Department of Anesthesiology, Leiden 
University Medical Center, Leiden, The Netherlands.
Ability of the Nociception Level, a Multiparameter 
Composite of Autonomic Signals, to Detect Noxious 
Stimuli during Propofol–Remifentanil Anesthesia
Chris	H.	Martini,	M.D.,	Martijn	Boon,	M.D.,	Suzanne	J.	L.	Broens,	M.D.,	Evelien	F.	Hekkelman,	M.D.,	
Lisanne	A.	Oudhoff,	M.D.,	Anna	Willemijn	Buddeke,	M.D.,	Albert	Dahan,	M.D.,	Ph.D.
Copyright © 2015, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.<zdoi;10.1097/ALN.0000000000000757>
Anesthesiology 2015; 123:00-00 2 Martini et al.
Nociception during Anesthesia
interactions.12,13 We measured the NoL, HR, and arterial 
blood pressure during induction of general propofol–remi-
fentanil anesthesia, intubation, and incision. Our aims were 
to validate the NoL as measured in real time by assessing its 
ability to detect moderate and intense nociceptive stimuli 
under different target remifentanil blood concentrations. 
The NoL was compared with the more commonly used indi-
ces of nociception, mean arterial pressure (MAP), and HR.
Materials and Methods
The protocol was performed after obtaining approval 
from the local Human Ethics Committee (Commis-
sie Medische Ethiek, Leiden University Medical Center, 
Leiden, The Netherlands) and was registered at www.clin-
icaltrials.gov under number NCT01912118. All patients 
gave oral and written informed consent before enrolment 
into the study. The study was performed from July 2013 
to June 2014.
Patients
American Society of Anesthesiology class I, II, or III 
patients (age, 18 to 80 yr) of either sex, scheduled for elec-
tive surgery under general anesthesia, were recruited to par-
ticipate in the study. Exclusion criteria included inability to 
give informed consent, pregnancy or lactation, body mass 
index more than 35 kg/m2, perceived difficult intubation, 
planned rapid sequence intubation, and use of β-adrenergic 
receptor antagonists. Preoperative preparation was accord-
ing to local protocol.
Study Design
In this prospective randomized study, patients received total 
intravenous anesthesia with propofol and remifentanil. 
Seventy-two patients were randomly assigned to one of six 
possible remifentanil target concentrations: 0 (propofol only, 
n = 12), 1, (n = 12), 2 (n = 12), 3 (n = 12), 4 (n = 12), and 
5 (n = 12) ng/ml, using a custom-built remifentanil tar-
get controlled infusion pump (Remifusor, University of 
Glasgow, United Kingdom) programmed with the remifen-
tanil pharmacokinetic dataset published by Minto et al.14 
Similarly, propofol was infused using a target-controlled 
infusion system (Orchestra Base Primea, Fresenius Kabi, 
The Netherlands) programmed with the propofol pharma-
cokinetic dataset published by Marsh et al.15 The target was 
adapted such that before intubation or skin incision the 
bispectral index (BIS) of the electroencephalogram (BIS® 
VISTA, Covidien, Ireland) was maintained at 45 ± 5 for at 
least 10 to 15 min. If needed, a muscle relaxant (rocuronium, 
0.5 mg/kg) could be given before intubation.
In the protocol, there were two additional study groups 
(n = 12, BIS, 70; remifentanil, 3 ng/ml; and n = 12, BIS, 30; 
remifentanil, 3 ng/ml). After enrolment of four subjects in 
this subprotocol, further inclusion of subjects was stopped 
because of safety concerns (e.g., possibility of awareness, 
hemodynamic instability).
Data Collection
A finger probe containing sensors for measurement of the 
photoplethysmogram, the Galvanic skin response, skin 
temperature, and three-axis accelerometer was placed on 
the index finger of the right hand (Medasense Biometrics, 
Israel).2,16 The signals from the probe were sampled at 50 
Hz and recorded on a laptop computer using the PMD-10X 
system and software (Medasense Biometrics). All data were 
processed offline using MATLAB R2011b software (The 
Mathworks Inc., USA). The following variables were calcu-
lated from the finger probe as specified by Ben-Israel et al.2: 
HR, HRV, AP, skin conductance level, and fluctuations in 
skin conductance. To measure the noninvasive beat-to-beat 
blood pressure, an appropriately sized finger cuff was applied 
to the mid-phalanx of the left index finger, which was con-
nected to a Nexfin monitor (Edwards Lifesciences, USA). 
Refer the study by Martina et al.17 for an elaborate explana-
tion of the Nexfin system and calculation of blood pressure. 
The beat-to-beat finger arterial blood pressure was stored 
on disc for offline analysis. The PMD-10X and the Nexfin 
systems were time aligned before each study. Data were col-
lected from induction of anesthesia until 3 to 5 min after 
incision. Specific events occurring during the study (start 
of induction, patient movement, intubation, and incision) 
were logged in the PMD-10X software program enabling a 
direct link between stimulus and measurements.
Description of the Nociception Level Index
The NoL is based on a nonlinear combination of nocicep-
tion-related physiologic parameters: HR, HRV (at the 0.15 
to 0.4 Hz band power), amplitude of the photoplethysmo-
graph wave, skin conductance level, number of skin con-
ductance fluctuations, and their time derivatives.2 The NoL 
index was developed to correlate with a reference clinical 
score of nociception based on the estimated opioid concen-
tration and stimulus strength (i.e., the combined index of 
stimulus and analgesia [CISA]). A composite parameter was 
derived from random forest analysis,12,13 a nonlinear regres-
sion method, in which the physiologic signals with their 
derivatives were used as predictor variables and the CISA 
was used as the observed variable. The estimated multipa-
rameter composite derived from the regression analyses was 
scaled from 0 to 100 to produce the NoL. The NoL index 
has been shown to provide a better indication of nociception 
than each of its component physiologic signals and to their 
linear combination.2 In the current study, the NoL index 
was calculated from the extracted signals by the PMD-10X 
software/hardware system using the algorithm derived from 
the learning study by Ben-Israel et al.2 The NoL device has 
not received Food and Drug Administration clearance as yet 
and is still under investigation.
Data Analysis
Because this study was the first assessment of the NoL 
in a clinical perioperative setting using total propofol/
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remifentanil anesthesia, we were uninformed regarding the 
possible effect sizes of the three stimuli on the NoL. We 
somewhat arbitrarily set the sample size at 12 subjects per 
remifentanil treatment level or 72 patients in total, a number 
very similar to several previous studies linking physiologic 
signals to nociception.9,11
Statistical and data analyses were performed using MAT-
LAB R2011b software (The Mathworks Inc.). Three dis-
tinct stimuli were defined in each patient: a nonnoxious 
event, incision, and intubation, which were regarded as 
nonnoxious, moderate noxious, and severe noxious stimuli, 
respectively.2,18,19 We graded the nociceptive intensity, non-
noxious event > incision > intubation, based on the previous 
studies that showed that the opioid concentration needed to 
suppress the autonomic response to intubation exceeds the 
concentration required to suppress the response to skin inci-
sion by a factor of 2.18,19 A nonnoxious event was defined 
as a 1-min interval within a 5-min window of absence of 
noxious stimulation; intubation was defined as the time 
interval around the insertion of the oropharyngeal tube 
into the trachea and included the preceding laryngoscopy; 
incision was defined as the time interval around the surgi-
cal skin incision. For each stimulus, two parameter values 
were defined, one before stimulation (before) and one after 
stimulation (after), which were the average of data before 
and after the stimulus along a certain time interval. These 
time intervals were the first (before) and last (after) 30 s of 
the 1-min nonnoxious interval for the nonnoxious stimulus 
and the 30 to 60s before the stimulus (before) and the 10 to 
180 s after the stimulus (after) for incision and intubation. 
Analysis was done on both the absolute MAP, HR, and NoL 
values and the difference between after and before values 
(i.e., Δ). In case of use of vasoactive (e.g., ephedrine and 
phenylephrine) and vagolytic (e.g., atropine) drugs in these 
time windows, the data were discarded.
Statistical Analysis
The following statistical tests were performed to compare 
the performance of NoL, ΔNoL, MAP, ΔMAP, HR, and 
ΔHR:
 1.  Right-tailed paired t test to assess whether the aver-
age reaction (Δ) of the three variables to stimula-
tion are significantly greater than 0. Two-tailed 
unpaired t test to assess whether the population 
values of the variables after stimulation were sig-
nificantly different from the values obtained before 
stimulation. In addition, the effect of stimulation 
on BIS was tested using paired and unpaired t tests.
 2.  Receiver operating characteristic (ROC) curves were 
constructed to assess the ability of the individual vari-
ables (absolute values and Δ) to discriminate between 
noxious and nonnoxious events. CIs of the area under 
the ROC curves (AUCs) were calculated using the 
method suggested by Hanley and McNeil,20 which 
corrects for the use of correlated data.
 3.  Repeated measures ANOVA to test the ability 
of each of the variables to grade noxious stimuli, 
i.e., to assess whether the variable values increased 
with an increasing stimulus strength: nonnoxious 
stimulus <  moderate noxious stimulus (incision) < 
intense noxious stimulus (intubation). In case of a 
significant main and interaction terms, a Scheffe 
post hoc multiple comparison test was applied to 
test between pairs nonnoxious stimulus versus intu-
bation, nonnoxious stimulus versus incision, and 
incision versus intubation.
 4.  For nonnoxious stimuli and intubation, the Spear-
man correlation coefficient was calculated to quan-
tify the relation between HR, MAP, NoL, and the 
remifentanil target concentration. This was done 
separately for time intervals before and after stimu-
lation. A quadratic polynomial was fitted by least 
square analysis to the data.
Results
Seventy-two patients participated in the study according 
to protocol (data from the subprotocol are not considered 
here). The characteristics of the 72 participating patients are 
given in table 1. The complete dataset of one subject was lost 
because of technical problems. The data from 71 patients 
were used in the analysis. All patients completed the study 
without side effects. In about half of the patients, a muscle 
relaxant was administered before intubation. Before nox-
ious stimulation (intubation/skin incision), BIS values were 
on average of 45.0 ± 9.0 (mean ± SD), 45.6 ± 9.9, 47.2 ± 9.1, 
42.6 ± 7.4, 44.7 ± 8.0, and 47.0 ± 9.8 in the 0, 1, 2, 3, 4, 
and 5 ng/ml remifentanil groups, respectively (repeated 
measures ANOVA: P > 0.05; grand mean, 45.5 ± 8.8). 
Because of technical (e.g., monitor failure), logistic 
(e.g., change of surgical plan), or other reasons (e.g., 
 hypertension/hypotension or bradycardia in response to 
low/high remifentanil requiring the use of vasoactive/vago-
lytic drugs; lack of annotations) that caused an inadvertent 
breach of protocol, the datasets missed one of the noxious/
nonnoxious stimuli in 20 to 25% of cases. The numbers of 
excluded events are given in table 2.
Response to Noxious Events
The effect of nonnoxious stimuli, incision, and intubation on 
BIS, HR, MAP, and NoL are given in figure 1. Nonnoxious 
stimuli had no effect on any of the variables when comparing 
before with after time intervals (mean difference [95% CI]): 
ΔBIS, −0.1 (−0.9 to 0.7); ΔHR, −0.13/min (−0.7 to 0.3/min); 
ΔMAP, −0.45 mmHg (−1.9 to 2.1 mmHg); and ΔNoL 
−1.1 (−3.6 to 2.0). Intubation caused an increase in HR, 
MAP, and NoL but not BIS: ΔBIS, 1.7 (−3.9 to 6.3; not 
significant [ns]); ΔHR, 7.0/min (1.4 to 12.0/min; 
paired t test, P < 0.001; unpaired t test, P < 0.001); 
ΔMAP, 13.0 (3.1 to 20; paired t test, P < 0.001; unpaired 
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t test, P < 0.001); and ΔNoL, 18.0 (7.8 to 29.0; paired 
t test, P < 0.001; unpaired t test, P < 0.001). Incision had 
no effect on BIS and HR but caused increases in MAP and 
NoL, although, in contrast to MAP, the effects on NoL 
were significant in both paired and unpaired t tests: ΔBIS, 
0.92 (−1.2 to 3.3; ns); ΔHR, 1.3/min (−0.46 to 3.1/min; 
ns); ΔMAP, 7.9 mmHg (−1.9 to 13.0 mmHg; paired t test, 
P < 0.001; unpaired t test, ns); and ΔNoL, 8.0 (0.4 to 16.0; 
paired t test, P < 0.001; unpaired t test, P < 0.001).
Comparing the three different stimuli (i.e., assuming non-
noxious event ≠ incision ≠ intubation), a significant main 
and interaction effect was observed for HR, MAP, and NoL 
after (but not before) stimulation and Δs: HR F(2,96) = 9.4, 
P < 0.001; ΔHR F(2,96) = 27, P < 0.0001); MAP 
F(2,80) = 28, P < 0.001; ΔMAP F(2,80) = 19, P < 0.0001; 
NoL F(2,96) = 23, P < 0.0001; ΔNoL F(2,96) = 46, 
P < 0.0001. Post hoc analysis showed that only NoL (after 
stimulation) and ΔNoL graded the level of noxious inten-
sity with nonnoxious NoL <  incision NoL < intubation 
NoL. HR after stimulation and ΔHR could not differenti-
ate between nonnoxious stimuli and incision (P = 0.24). 
ΔMAP could not discriminate between incision and intu-
bation (P = 0.07). See also Supplemental Digital Content 
1, tables 1 and 2, http://links.lww.com/ALN/B170.
The ROC curves, calculated (n = 71) for HR, MAP, 
and NoL (all after stimulation), and ΔHR, ΔMAP, and 
ΔNoL, are shown in figures 2 and 3. ROC areas under 
the curve sensitivity values at a specificity of 75% are 
given in table 3. ΔNoL outperformed all other vari-
ables in ability to discriminate between noxious (intuba-
tion or incision) and nonnoxious events with an AUC 
of 0.95 (95% CI, 0.91 to 0.99). The ΔNoL AUC was 
significantly larger compared with all other variables 
(P = 0.0003 vs. ΔHR; P < 0.0001 vs. ΔMAP; P < 0.0001 
vs. HR; P = 0.00004 vs. MAP). Moreover, NoL after 
stimulation outperformed MAP and HR in classify-
ing noxious stimuli (AUC, 0.82; 95% CI, 0.75 to 0.89, 
P = 0.001 vs. HR; P = 0.035 vs. MAP). The NoL outper-
formed HR and MAP and ΔNoL outperformed ΔHR 
and ΔMAP in terms of sensitivity, specificity, and positive 
and negative predictive values for the detection of noxious 
Table 1. Patient Characteristics for the Six Study Groups and Performed Surgical Procedures
REMI 0 REMI 1 REMI 2 REMI 3 REMI 4 REMI 5 All
N 12 12 12 12 12 12 72
M/F 6/6 3/9 9/3 4/8 3/9 8/4 33/39
Age, yr (range) 43 (20–75) 57 (24–74) 56 (37–69) 55 (21–74) 54 (26–76) 54 (31–73) 54 (20–76)
Height (cm) 176 ± 1 169 ± 6 181 ± 9 171 ± 9 170 ± 9 176 ± 13 174 ± 10
Weight (kg) 81 ± 16 67 ± 12 84 ± 15 70 ± 11 69 ± 12 79 ± 16 75 ± 15
BMI 26 ± 5 24 ± 4 26 ± 4 24 ± 3 24 ± 3 26 ± 4 25 ± 4
Heart rate (beats/min)* 79 ± 10 74 ± 15 72 ± 15 73 ± 10 70 ± 13 74 ± 18 73 ± 14
MAP (mmHg)* 90 ± 12 99 ± 14 96 ± 14 101 ± 19 96 ± 18 100 ± 10 97 ± 15
ASA I (n) 7 5 5 5 9 8 39
ASA II (n) 5 6 7 7 3 4 32
ASA III (n) 0 1 0 0 0 0 1
General surgery (n) 4 4 5 5 4 8 30
Gynecology (n) 4 4 2 1 1 4 16
Urology (n) 3 2 3 2 1 11
Orthopedics (n) 1 1 2 4
ENT (n) 1 1 2 4
Neurosurgery (n) 1 1
Oral surgery (n) 1 1
Plastic surgery (n) 3 2 5
All values are represented as mean ± SD or numbers (n), except age that is represented as median (range).
* Values obtained at patient screening in the preoperative clinic.
ASA = American Society of Anesthesiologists; BMI = body mass index; ENT = ear, nose, and throat surgery; F = female; M = male; MAP = mean arterial 
pressure; REMI = remifentanil target concentration.
Table 2. Reason for Missing or Discarded Data
Device
Number of Subjects 
Included in the 
Analysis
Number of Subjects  
with Missing  
Data (A/B/C)
Nonnoxious stimulus
  PMD-10X 63 0/0/9
  Nexfin device 56 7/0/9
  BIS® monitor 56 7/0/9
Incision
  PMD-10X 58 1/5/8
  Nexfin device 53 3/5/8
  BIS® monitor 56 3/5/8
Intubation
  PMD-10X 67 0/2/3
  Nexfin device 65 2/2/3
  BIS® monitor 66 1/2/3
A = technical problems; B = clinical issues (hypotension/hypertension/
bradycardia); BIS = bispectral index of the electroencephalogram; C = lack 
of annotation.
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stimuli (table 3). For NoL a cutoff value between noxious 
and nonnoxious stimuli of 16 yielded a specificity and sen-
sitivity of 80 and 73%.
Response to Intubation under Different Remifentanil 
Target Concentrations
The effects of increasing concentrations of remifentanil on 
HR (n = 57), MAP (n = 50), and NoL (n = 57) before and 
after noxious stimulation are shown in figures 4 to 6. The 
NoL before and after nonnoxious stimulation showed no 
significant correlation with the remifentanil concentration 
(rS = −0.047 and 0.024, P > 0.05; fig. 4, A and B). The before 
and after intubation NoL values showed a significant Spear-
man correlation with rS = −0.3, P < 0.05 (before, fig. 4C) and 
rS = −0.51, P < 0.001; after, fig. 4D). The analysis indicates 
that with increasing remifentanil concentrations, the NoL 
response to intubation decreases significantly with the  smallest 
response observed at a remifentanil target concentration of 
5 ng/ml (fig. 4D). HR before and after  nonnoxious stimu-
lation and intubation decreased significantly with increas-
ing remifentanil concentrations (P < 0.01; fig. 5, A–D). 
A similar observation was made for MAP before and after 
nonnoxious stimulation and intubation (P < 0.05; fig. 6, A–D).
Discussion
In this validation study, the NoL, a novel multidimensional 
parameter, was used to detect nociceptive events during 
propofol–remifentanil anesthesia. The variables that make 
up the NoL cover both sympathetic and parasympathetic 
Fig. 1. Bispectral index (BIS) (A), heart rate (HR) (B), mean arterial pressure (MAP) (C), and nociceptive level (NoL) (D) before 
and after noxious stimulation for nonnociceptive conditions, incision, and intubation. *Paired t test, P < 0.001; #unpaired t test, 
P < 0.001. Open symbol = before stimulation; closed symbol = after stimulation.
Fig. 2. Discrimination between nociceptive (incision and 
intubation) and nonnociceptive stimuli: receiver operating 
curves of heart rate, mean arterial pressure (MAP), and the 
composite parameter, the nociception level (NoL).
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activities of the autonomous nervous system.21 The main 
observations from our study are that (1) the NoL is able to 
detect intense noxious stimulation (intubation) and moder-
ate nociceptive stimuli (incision). In this respect, the NoL 
outperformed the standard variables (HR and MAP) that 
were sensitive to intubation but to a lesser extent to incision. 
Furthermore, as based on the AUC of the ROC, the NoL 
was best in differentiating noxious from nonnoxious stimuli; 
and (2) the NoL was significantly correlated with the target 
remifentanil concentration after noxious stimulation. Simi-
lar observations were made for HR and MAP; however, in 
contrast to HR and MAP, the NoL was not affected by non-
noxious events.
Various previous studies have relied on single signals 
to assess nociception during surgery.3–11,22 For example, 
indices from the high-frequency component of HRV were 
used to evaluate surgical nociception and analgesia during 
anesthesia and to predict postoperative pain based on the 
measurements before extubation.3,22 Another example is the 
measurement of changes in skin conductance, which is based 
on the sympathetically induced secretion of sweat, which 
increases skin conductance.4 This response (i.e., nociception-
related sweating) is unrelated to hemodynamic changes. All 
single indices aimed at detecting nociception share that they 
are surrogate markers of the autonomic nervous system and 
show a large within- and between-subject variability.2,23 
Another approach in detecting nociception during surgery 
is the use of multiparameter indices.8–10 Several studies show 
that a multiparameter approach yields greater sensitivity and 
specificity in discriminating between noxious and nonnox-
ious stimuli than the single-signal approach.2,11,16 Examples 
of multiparameter indices are the Surgical Pleth or Stress 
Index (which combines HR and AP),9 the response index 
of nociception (which combines parameters from the elec-
troencephalographic and hemodynamic signals),11 and the 
composite variability index (which combines the variability 
of the forehead electromyogram and BIS of the electroen-
cephalogram).11 In the current study, we applied the mul-
tiparameter NoL to assess nociceptive responses at three 
levels of increasing nociceptive intensity. The NoL showed a 
remifentanil dose-independent increase in noxious response 
from −1.1 (nonnoxious stimulus) to 8.0 (incision) and 18.0 
(intubation), with significant increases (Δ signal) occurring 
for incision and intubation (fig. 1). This contrasts with the 
two other variables that were tested, the commonly used HR 
and MAP, which on a population level did show significant 
increases at intense stimulation but not at moderate noxious 
stimulation. The ROC curves (figs. 2 and 3; table 2) showed 
that of all tested Δ signals, ΔNoL was best at differentiat-
ing between noxious and nonnoxious stimuli (AUC, 0.95). 
Similar observations were made for NoL (AUC, 0.82) rela-
tive to HR (0.66) and MAP (0.73). Cutoff values of 16 for 
NoL yielded an acceptable sensitivity of 73% with specificity 
of 80% and could be interpreted as a cutoff for discriminat-
ing noxious from nonnoxious stimuli. Furthermore, when 
testing the effect of multiple target concentrations of remi-
fentanil, the NoL, in contrast to HR and MAP, remained 
unaffected under nonnociceptive conditions. This indicates 
that the NoL was a more reliable measure of nociception per 
Table 3. AUC, Sensitivity, PPV, and NPV of the NoL, ΔNoL, HR, ΔHR, MAP, and ΔMAP at a Specificity of 75%
Variable AUC (95% CI) Sensitivity (%) Specificity (%) PPV (%) NPV (%)
HR 0.66 (0.56–0.75) 63 75 72 65
MAP 0.73 (0.64–0.81) 63 75 75 64
NoL 0.82 (0.75–0.89)* 73 75 75 72
ΔHR 0.84 (0.77–0.91) 84 75 78 81
ΔMAP 0.78 (0.70–0.86) 75 75 78 72
ΔNoL 0.95 (0.91–0.99)† 94 75 80 92
Random classifier 0.50 25 75 50 50
Statistical test was performed according to Hanley and McNeil.20 NoL, MAP, and HR given were obtained after noxious stimulation.
* P = 0.001 vs. HR; P = 0.036 vs. MAP. † P = 0.0003 vs. ΔHR; P < 0.001 vs. ΔMAP; P = 0.0001 vs. ΔNoL; P < 0.0001 vs. HR; P < 0.0001 vs. MAP.
AUC = area under the receiver operating characteristic curve; HR = heart rate; MAP = mean arterial pressure; NoL = nociception level; NPV = negative 
predictive value; PPV = positive predictive value.
Fig. 3. Receiver operating curves of the hemodynamic 
Δ signals and the Δ nociceptive level (ΔNoL). MAP = mean 
arterial pressure.
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se, whereas HR and MAP are additionally affected by the 
hemodynamic effects of remifentanil (figs. 4–6).
Treister et al.16 studied the same index response to three 
intensities of noxious stimulation in awake volunteers. 
Although none of the signals that make up the NoL were 
able to discriminate between the different noxious intensi-
ties, they observed, in agreement with our findings, that the 
combination of parameters (i.e., the NoL) was able to differ-
entiate between pain and no pain and also between all three 
noxious intensities. This indicates that the NoL performs 
equally well in the awake and anesthetized individuals. Inter-
estingly, single indices, such as HRV, perform better under 
conditions of general anesthesia than the awake state.24 Also 
in chronic pain patients, the ability to obtain objective and 
accurate measures of pain and nociception, next to subjec-
tive self-reports (that are often colored by a variety of bio-
psychosocial factors), is important.21 To assess the ability of 
the NoL to track nociception in patients with chronic pain, 
Ben-Israel et al.25 studied patients with chronic radicular 
pain treated with spinal cord stimulation (SCS). The NoL 
values were in accordance with the efficacy of the SCS treat-
ment as presented a correlation between reported pain score 
while turning the SCS device on and off. This indicates that 
the multivariate NoL may be used as an objective measure-
ment of pain in patients with chronic pain and evaluate the 
efficacy of treatment.
The NoL is based on the advanced statistical and machine 
learning techniques to combine multiple signals into a single 
composite index. Machine learning methods rely on the con-
cept that a specific algorithm that connects input to output can 
be trained to discover their optimal relationship. In our case, 
the link between input and output was established in a previ-
ous learn study, where the input were the records of physiologic 
signals collected during surgery under general anesthesia and 
the output the CISA, which is the linear combination of stim-
ulus intensity and estimated analgesic plasma concentration.2  
A detailed description of the CISA can be found in Ref. 2. The 
different autonomic variables that make up the NoL represent 
Fig. 4. Boxplot of the effect of remifentanil on nociception level (NoL) before (A) and after (B) noxious stimulation for nonnoci-
ceptive conditions and before (C) and after (D) noxious stimulation for intubation. Boxplots represent the median and 25th and 
75th percentiles, and the whiskers extend to the most extreme data points; outliers are plotted individually (block dots). The 
Spearman correlation is given (rS), with *P < 0.05 and ***P < 0.001. A quadratic polynomial is fitted to the data to guide the eye.
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different underlying systems, which have nontrivial nonlin-
ear interactions. Adding their time derivatives to the equation 
(which is done to increase the ability to obtain a more reliable 
estimate of nociception) introduces an additional level of com-
plexity by significantly enlarging the number of variables and 
creating additional nonlinear dependencies. Machine learn-
ing was performed using random forest regression analysis, a 
technique that is able to handle a large number of predictors 
to discover the optimal algorithm combining input to output, 
without the need for an a priori specification of a stochastic 
data model (i.e., the created algorithmic model treats the data 
mechanisms as unknown).12,13 Random forest regression is 
applied in different areas of science and engineering such as the 
identification of the smallest possible set of genes that can still 
achieve a good predictive outcome in clinical tests, prediction 
of protein interactions, and forecasting murderous conduct by 
individuals on probation or parole.26–28
An important issue is whether continuous measure-
ment of nociception during surgery and treatment of 
signs of increased nociception will improve patient out-
come. Chen et al.9 addressed this issue by studying the 
effect of surgical stress index–guided propofol–remifent-
anil anesthesia in patients undergoing elective ear, nose, 
and throat surgery. Compared with standard of practice, 
nociception-guided anesthesia reduced remifentanil con-
sumption and unwanted movement and hemodynamic 
events. Parker et al.29 showed that the catecholamine 
(stress) response during anesthesia and emergence, in 
patients undergoing lower extremity revascularization, 
contributed to the development of postoperative hyper-
tension and possibly also to the occurrence of throm-
botic events. Similarly, also anesthesia with overdoses in 
anesthetic and opioid delivery may be associated with a 
poor outcome.30,31 Cumulatively these data suggest that 
the prevention of overdosing or underdosing of opioid 
and anesthetic drug delivery by continuous monitoring 
of nociception (and possibly also indices from the electro-
encephalogram) may result in a more stable nociceptive 
Fig. 5. Boxplot of the effect of remifentanil on heart rate before (A) and after (B) noxious stimulation for nonnociceptive conditions 
and before (C) and after (D) noxious stimulation for intubation. Boxplots represent the median and 25th and 75th percentiles, and 
the whiskers extend to the most extreme data points; outliers are plotted individually (black dots). The Spearman correlation is 
given (rS), with **P < 0.01 and ***P < 0.001. A quadratic polynomial is fitted to the data to guide the eye.
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condition with beneficiary effects on outcome. Evidently, 
further studies are needed to fully understand the com-
plexities of anesthetic monitoring and outcome.
The current study has some limitations: (1) the level 
of anesthetic depth as measured by the BIS was fixed to 
values ranging between 40 and 50. Therefore, we remain 
unaware of the influence of variations in anesthetic depth 
at multiple target opioid concentrations on the NoL. 
Assuming a synergistic effect of remifentanil and propofol 
on nociception,32 we expect some effect of propofol on the 
NoL. Our subprotocol was intended to study this issue but 
was not completed. Data were collected in four patients 
(two at BIS 30 and two at BIS 70). The analysis of these 
data suggests no dependency on BIS value on the effect of 
intubation on the NoL (data not shown). Evidently, this 
issue requires further study. (2) Each subject only received 
one dose level of remifentanil. This precluded the assess-
ment of the intraindividual variance in the response to 
remifentanil. (3) We used a finger cuff system (Nexfin) 
to noninvasively measure the beat-to-beat blood pressure 
rather than invasive blood pressure. This finger cuff tech-
nique is reliable,17 and Nexfin MAP measurements were 
second to the NoL in ability to detect nociceptive responses 
(fig. 2). Possibly adding the beat-to-beat MAP to the NoL 
algorithm would further improve the accuracy of the NoL. 
(4) We performed our studies in 72 patients. Because of 
technical, logistic, or other issues, nonnoxious, incision, 
and intubation events were obtained on average in 60 
(83%) subjects. This may have affected the outcome of the 
study. Given the fact that the NoL performed as expected 
from results of previous studies, the loss of data did not 
affect the power of our study with respect to the NoL.2,16 
Conversely, the loss of data may have caused the inabil-
ity of MAP to detect moderate nociceptive stimuli (fig. 1). 
(5) Finally, we excluded patients on β-adrenergic-blocking 
drugs. Because β-adrenergic blockers and other vasoactive 
drugs affect the autonomic system at multiple sites, their 
effect on the accuracy of the NoL requires further study.
Fig. 6. Boxplot of the effect of remifentanil on mean arterial pressure (MAP) before (A) and after (B) noxious stimulation for non-
nociceptive conditions and before (C) and after (D) noxious stimulation for intubation. Boxplots represent the median and 25th 
and 75th percentiles, and the whiskers extend to the most extreme data points; outliers are plotted individually (black dots). The 
Spearman correlation is given (rS) with *P < 0.05 and ***P < 0.001. A quadratic polynomial is fitted to the data to guide the eye.
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In conclusion, we applied a novel multidimensional 
index, the NoL, to detect nociception during conditions 
of no, moderate, and intense noxious stimulation in sur-
gical patients under propofol–remifentanil anesthesia. We 
observed that compared with HR and MAP, the index was 
best at differentiating nociceptive from nonnociceptive con-
ditions. In additionally, in contrast to MAP and HR, the 
NoL remained unaffected by the hemodynamic effects of 
increasing concentrations of remifentanil.
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